<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01303250</url>
  </required_header>
  <id_info>
    <org_study_id>UKM09_0031</org_study_id>
    <secondary_id>2009-017595-25</secondary_id>
    <secondary_id>04-AnIt-09</secondary_id>
    <nct_id>NCT01303250</nct_id>
  </id_info>
  <brief_title>Perioperative Colloid vs Crystalloid in Patients Undergoing Colorectal Surgery</brief_title>
  <acronym>KoKris</acronym>
  <official_title>Balanced 6 % HES 130/0.4 vs. Balanced Crystalloid-based Infusion in Patients Undergoing Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Muenster</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to determine the effect of a balanced 6%hydroxyethyl
      starch 130/0.4 vs. a balanced crystalloid in colorectal surgery. The intraoperative fluid
      management will be given to optimize the stroke volume variation &lt;= 12%.

      The investigators hypothesize that patients in the intervention group will need less fluid
      administration be optimal hemodynamic stabilized.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The final decision of the review of HES-containing solution shall be awaited.
  </why_stopped>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total amount of administered fluids</measure>
    <time_frame>intraoperatively</time_frame>
    <description>Total amount of administered fluids intraoperatively that is necessary to keep patients optimal hemodynamic stabilized</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of surgery related complications</measure>
    <time_frame>day 28 and 90 postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Surgery, Colorectal</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A balanced hydroxyethyl starch 130/0.4 will be used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A balanced crystalloid will be used</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>balanced 6% hydroxyethylstarch 130/0.4</intervention_name>
    <description>Fluid administration and optimization based on cardiac output findings during surgery.</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>balanced crystalloid</intervention_name>
    <description>Fluid administration and optimization based on cardiac output findings during surgery.</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing elective colorectal surgery

          -  minimum age 18 years

          -  informed consent

        Exclusion Criteria:

          -  patients with severe cardiomyopathy or severe heart failure

          -  history of coagulation disorders

          -  intracranial hemorrhage

          -  patients with severe cardiovascular or respiratory disorders

          -  renal insufficiency

          -  severe liver diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugo Van Aken, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesia and Intensive Care, University Hospital Muenster</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>D-48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2011</study_first_submitted>
  <study_first_submitted_qc>February 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2011</study_first_posted>
  <last_update_submitted>December 17, 2015</last_update_submitted>
  <last_update_submitted_qc>December 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>goal-directed fluid optimization</keyword>
  <keyword>hemodynamic optimization</keyword>
  <keyword>crystalloid</keyword>
  <keyword>colloid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

